Alembic Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held on April 27, 2016, has recommended a dividend of Rs 4.00 (200%) per Equity Share of face value of Rs 2 each, subject to approval of Shareholders at the ensuing Annual General Meeting, appointed Chirayu Amin as Executive Chairman and Chief Executive Officer with effect from April 27, 2016, appointed Pranav Amin as Managing Director with effect from April 27, 2016, and appointed Shaunak Amin as Managing Director with effect from April 27, 2016.
The above information is a part of company’s filings submitted to BSE.
